Cerity Partners’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Buy |
163,620
+43,421
| +36% | +$3.5M | 0.02% | 615 |
|
|
2026
Q1 | $8.5M | Buy |
120,199
+15,213
| +14% | +$1.14M | 0.01% | 776 |
|
|
2025
Q4 | $8.29M | Sell |
104,986
-21,465
| -17% | -$1.7M | 0.01% | 724 |
|
|
2025
Q3 | $10.4M | Buy |
126,451
+33,144
| +36% | +$2.61M | 0.02% | 566 |
|
|
2025
Q2 | $7.5M | Buy |
93,307
+9,863
| +12% | +$761K | 0.01% | 645 |
|
|
2025
Q1 | $6.7M | Buy |
83,444
+13,037
| +19% | +$1.08M | 0.01% | 623 |
|
|
2024
Q4 | $5.78M | Buy |
70,407
+718
| +1% | +$59.7K | 0.01% | 656 |
|
|
2024
Q3 | $5.75M | Buy |
69,689
+27,274
| +64% | +$2.04M | 0.01% | 649 |
|
|
2024
Q2 | $2.98M | Sell |
42,415
-10,368
| -20% | -$740K | 0.01% | 760 |
|
|
2024
Q1 | $3.91M | Buy |
52,783
+28,569
| +118% | +$1.99M | 0.01% | 728 |
|
|
2023
Q4 | $1.6M | Buy |
24,214
+5,178
| +27% | +$324K | 0.01% | 833 |
|
|
2023
Q3 | $1.2M | Sell |
19,036
-4,911
| -21% | -$306K | 0.01% | 703 |
|
|
2023
Q2 | $1.35M | Buy |
23,947
+3,530
| +17% | +$196K | 0.01% | 827 |
|
|
2023
Q1 | $3.65M | Sell |
20,417
-577
| -3% | -$38.9K | 0.01% | 556 |
|
|
2022
Q4 | $1.8M | Buy |
20,994
+2,462
| +13% | +$176K | 0.01% | 540 |
|
|
2022
Q3 | $1.13M | Buy |
18,532
+4,696
| +34% | +$300K | 0.01% | 488 |
|
|
2022
Q2 | $869K | Buy |
13,836
+6,227
| +82% | +$412K | 0.01% | 586 |
|
|
2022
Q1 | $535K | Buy |
7,609
+2,358
| +45% | +$159K | 0.01% | 575 |
|
|
2021
Q4 | $327K | Buy |
+5,251
| New | +$330K | 0.01% | 740 |
|
|
2020
Q1 | – | Sell |
-5,373
| Closed | -$274K | – | 496 |
|
|
2019
Q4 | $274K | Sell |
5,373
-554
| -9% | -$26.7K | 0.01% | 444 |
|
|
2019
Q3 | $279K | Sell |
5,927
-1,931
| -25% | -$92.1K | 0.02% | 405 |
|
|
2019
Q2 | $390K | Sell |
7,858
-3,007
| -28% | -$141K | 0.02% | 355 |
|
|
2019
Q1 | $463K | Sell |
10,865
-4,121
| -27% | -$182K | 0.03% | 339 |
|
|
2018
Q4 | $615K | Sell |
14,986
-11,243
| -43% | -$482K | 0.04% | 289 |
|
|
2018
Q3 | $1.23M | Sell |
26,229
-3,009
| -10% | -$137K | 0.08% | 220 |
|
|
2018
Q2 | $1.27M | Sell |
29,238
-3,590
| -11% | -$167K | 0.09% | 212 |
|
|
2018
Q1 | $1.51M | Buy |
32,828
+6,300
| +24% | +$306K | 0.12% | 183 |
|
|
2017
Q4 | $1.34M | Sell |
26,528
-5,680
| -18% | -$299K | 0.09% | 202 |
|
|
2017
Q3 | $1.67M | Sell |
32,208
-4,529
| -12% | -$221K | 0.12% | 178 |
|
|
2017
Q2 | $1.8M | Buy |
36,737
+1,027
| +3% | +$47.6K | 0.15% | 127 |
|
|
2017
Q1 | $1.68M | Buy |
35,710
+431
| +1% | +$20.5K | 0.14% | 142 |
|
|
2016
Q4 | $1.69M | Buy |
+35,279
| New | +$1.62M | 2.33% | 17 |
|
Other funds holding MET
Cerity Partners's MET Position: Q2 2026 in Review
Cerity Partners increased its MetLife (MET) stake by 36% in Q2 2026, buying an estimated $3.5M and bringing the position to 163,620 shares worth $13.8M. The position accounts for 0.02% of the portfolio, ranked #615.
Cerity Partners first reported a position in MET in Q4 2016 and has held it in 32 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Cerity Partners held 163,620 shares of MetLife worth $13.8M as of Q2 2026.
- Cerity Partners bought 43,421 MetLife shares in Q2 2026, an estimated $3.5M.
- MetLife made up 0.02% of Cerity Partners's portfolio in Q2 2026, its #615 holding.
- Cerity Partners first reported a position in MetLife in Q4 2016 and has held it in 32 quarters since.
- 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.